Skip to main content

and
  1. Article

    Open Access

    Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer

    Although 70–80% of newly diagnosed ovarian cancer patients respond to first-line therapy, almost all relapse and five-year survival remains below 50%. One strategy to increase five-year survival is prolonging ...

    Stephen Shuford, Christine Wilhelm, Melissa Rayner, Ashley Elrod in Scientific Reports (2019)

  2. No Access

    Chapter and Conference Paper

    Classification of Ovarian Cancer: A Genomic Analysis

    Ovarian cancer is the most lethal gynecologic cancer, accounting for over 16,000 deaths. In the US annually (1). The poor prognosis of this disease is due to the lack of reliable screening tools, the late stag...

    Michael P. Stany, Tomas Bonome, Fred Wamunyokoli, Kristen Zorn in Ovarian Cancer (2008)